GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starpharma Holdings Ltd (FRA:PQ6) » Definitions » FCF Yield %

Starpharma Holdings (FRA:PQ6) FCF Yield % : -28.60 (As of Apr. 01, 2025)


View and export this data going back to 2004. Start your Free Trial

What is Starpharma Holdings FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Starpharma Holdings's Trailing 12-Month Free Cash Flow is €-6.87 Mil, and Market Cap is €22.81 Mil. Therefore, Starpharma Holdings's FCF Yield % for today is -28.60%.

The historical rank and industry rank for Starpharma Holdings's FCF Yield % or its related term are showing as below:

FRA:PQ6' s FCF Yield % Range Over the Past 10 Years
Min: -38.03   Med: -5.01   Max: -1.24
Current: -28.6


During the past 13 years, the highest FCF Yield % of Starpharma Holdings was -1.24%. The lowest was -38.03%. And the median was -5.01%.

FRA:PQ6's FCF Yield % is ranked worse than
63.02% of 1498 companies
in the Biotechnology industry
Industry Median: -15.025 vs FRA:PQ6: -28.60

Starpharma Holdings's FCF Margin % for the quarter that ended in Dec. 2024 was -107.36%.


Starpharma Holdings FCF Yield % Historical Data

The historical data trend for Starpharma Holdings's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starpharma Holdings FCF Yield % Chart

Starpharma Holdings Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.54 -2.57 -5.28 -12.35 -24.02

Starpharma Holdings Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.15 -15.02 6.59 -62.25 -10.38

Competitive Comparison of Starpharma Holdings's FCF Yield %

For the Biotechnology subindustry, Starpharma Holdings's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Starpharma Holdings's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Starpharma Holdings's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Starpharma Holdings's FCF Yield % falls into.


;
;

Starpharma Holdings FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Starpharma Holdings's FCF Yield % for the fiscal year that ended in Jun. 2024 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-4.359 / 18.144412
=-24.02%

Starpharma Holdings's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-1.226 * 2 / 23.6230455
=-10.38%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Starpharma Holdings FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Starpharma Holdings FCF Yield % Related Terms

Thank you for viewing the detailed overview of Starpharma Holdings's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Starpharma Holdings Business Description

Traded in Other Exchanges
Address
4-6 Southampton Crescent, Abbotsford, Melbourne, VIC, AUS, 3067
Starpharma Holdings Ltd is an Australia-based company engaged in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications. It focuses on the development of VivaGel for the management and prevention of bacterial vaginosis and as a condom coating and VIRALEZE an antiviral nasal spray.

Starpharma Holdings Headlines

No Headlines